Page 168 - Read Online

Ryabova et al. Vessel Plus 2019;3:17 I http://dx.doi.org/10.20517/2574-1209.2019.10 Page 3 of 3
targeting substances. This is a good arsenal for a broad search for potential drugs for subcellular therapy
[4,5]
including anti-atherosclerotic therapy .

DECLARATIONS
Authors’ contributions
Conducting experiments: Ryabova AV, Romanishkin ID, Skobeltsin AS, Moskalev AS, Makarov VI,
Nikiforov NG
Manuscript preparation: Loschenov VB, Orekhov AN
Manuscript editing: Sobenin IA

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported by the Russian Science Foundation (Grant # 19-15-00010).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Cai Y, Si W, Huang W, Chen P, Shao J, et al. Organic dye based nanoparticles for cancer phototheranostics. Small 2018;14:e1704247.
2. Kang HC. Mitochondria-targeting theranostics. Biomater Res 2018;22:34.
3. Sazonova MA, Ryzhkova AI, Sinyov VV, Galitsyna EV, Orekhova VA, et al. New markers of atherosclerosis: a threshold level of
heteroplasmy in mtDNA mutations. Vessel Plus 2017;1:182-91.
4. Orekhov AN, Ivanova EA. Introduction of the special issue “atherosclerosis and related diseases”. Vessel Plus 2017;1:163-5.
5. Nikiforov NG, Galstyan KO, Nedosugova LV, Elizova NV, Kolmychkova KI, et al. Proinflammatory monocyte polarization in type 2
diabetes mellitus and coronary heart disease. Vessel Plus 2017;1:192-5.